source
- Genentech CEO Ashley Magargee reflects on biotech origins and future amid growing startup ecosystemGenentech’s founder story was revisited in a recent interview with CEO Ashley Magargee. She recalled how co‑founder Herbert Boyer was initially skeptical of a brief meeting with venture capitalist…
- ai3Bio raises $48 million to develop T-cell targeting therapy for autoimmune diseaseai3Bio announced its emergence from stealth mode after securing $48 million in Series A funding. The round was led by UPMC Enterprises and Ziff Capital Partners and combines technology from Corner…